4//SEC Filing
Simonian Nancy A 4
Accession 0000950170-24-131591
CIK 0001556263other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 5:00 PM ET
Size
5.0 KB
Accession
0000950170-24-131591
Insider Transaction Report
Form 4
Simonian Nancy A
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-11-25$0.27/sh−134,713$35,739→ 41,070 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2604 to $0.2723, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001359574
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 5:00 PM ET
- Size
- 5.0 KB